Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more. - Wikidata - wikimedia - TriplyDB

Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more.

Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more.

http://www.wikidata.org/entity/Q33262818

about

The contribution of viral genotype to plasma viral set-point in HIV infection Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.Characteristics and outcomes among older HIV-positive adults enrolled in HIV programs in four sub-Saharan African countries Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.Total daily pill burden in HIV-infected patients in the southern United States.Mortality and immunological recovery among older adults on antiretroviral therapy at a large urban HIV clinic in Kampala, Uganda.A novel Acute Retroviral Syndrome Severity Score predicts the key surrogate markers for HIV-1 disease progression.Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.Age, sex, and nutritional status modify the CD4+ T-cell recovery rate in HIV-tuberculosis co-infected patients on combination antiretroviral therapy Risk factors for mortality during antiretroviral therapy in older populations in resource-limited settings.Individual and neighborhood predictors of mortality among HIV-positive Latinos with history of injection drug use, Florida, 2000-2011.Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels Definition of advanced age in HIV infection: looking for an age cut-off.Cost-effectiveness of HIV screening in patients older than 55 years of age.[Descriptive aspects of HIV/AIDS in patients aged 50 years and over followed at the Treatment Center of Bafoussam - Cameroon].Characteristics and Outcome of Patients Diagnosed With HIV at Older Age.Impact of age on markers of HIV-1 disease Impact of HIV and aging on neuropsychological function.HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD).Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa.Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals.HIV/AIDS epidemic among older adults in China during 2005-2012: results from trend and spatial analysis.A review of cardiovascular and renal function monitoring: a consideration of older adults with HIV.Pharmacologic consideration for the use of antiretroviral agents in the elderly.Personal barriers to antiretroviral therapy adherence: case studies from a rural Uganda prospective clinical cohort.Human immunodeficiency virus (HIV) in older people."The Pleasure Is Better as I've Gotten Older": Sexual Health, Sexuality, and Sexual Risk Behaviors Among Older Women Living With HIV.Sex and race effects on risk for selected outcomes among elderly HIV-infected patients.Ageing with HIV: health and psychosocial well-being of older gay men.Profiles of Elderly People Infected with HIV and Response to Antiretroviral Treatment in Burkina Faso: A Retrospective Cohort Study.HIV Awareness and Knowledge among Viewers of a Documentary Film about HIV among Racial- or Ethnic-Minority Older Adults.Traditional Chinese medicine could increase the survival of people living with HIV in rural central China: a retrospective cohort study, 2004-2012.Demographic and epidemiological characteristics of HIV opportunistic infections among older adults in Nigeria.Clinical and behavioural aspects of aging with HIV infection.Trends related to aging and co-occurring disorders in HIV-infected drug users.Clinicoepidemiological Profile of Elderly PLHIV Attending a Tertiary Care Center in South India.Ageing with HIV: newly diagnosed older adults in Italy.Post-traumatic growth as outcome of a cognitive-behavioural therapy trial for motor vehicle accident survivors with PTSD.HIV infection in the elderly.

P2860

Q33553778-8AE42023-3831-4330-9A3B-A5B52DD87211 Q33614467-13BA8294-AF43-4372-8B68-98048FD4E93B Q33958103-BE6B0B49-FF50-407F-A3BF-DE8D5DB827C8 Q33975574-C27F6A64-B6B2-42F0-8F81-0B2BFABA841E Q34100187-76C2A68D-4081-462A-915C-B526BFAE2B00 Q34269272-7344677D-256A-4042-A8E1-5DA978C9AA8A Q34443404-7D7CD813-2C82-4375-96C1-51126237BC88 Q34662516-EE8E5516-8B13-4CF0-A0A7-8C35EC8EE670 Q35111937-ED6861B6-4F73-464F-A1D7-0BC9BEABF2E4 Q35836400-BAE79C92-8251-4D68-BF29-536C1BC77643 Q35897165-3ECB530A-EA30-42BD-89CE-4B89C563BC0B Q35952168-85763362-34C7-41B4-AC74-365F0A398C45 Q36144187-8CCC4A34-0409-44B2-812D-4F64919051D1 Q36177972-91D48CA6-303A-4527-9025-A219054301CB Q36191220-2E49FBD3-3607-4598-A956-7D8152552EA5 Q36372447-FD780BA9-0C3C-4D6A-AB5B-4A2C688A2083 Q36445019-506F28C5-9A70-43A9-A3EA-0633C9520AC6 Q36763762-96C2816B-87E1-4738-B5D2-330C714C5DC0 Q36866613-34F3E7BC-1109-4EF0-B148-4C6F70137796 Q36946140-4F7452EA-3ECA-4B0C-944F-D8FE896676AC Q36992075-00010A2C-4C02-420C-BD69-CF196EC4D057 Q37003774-4701412A-79F3-4AB2-BDEE-7AEBDEC28097 Q37188732-2F34FF95-712B-41CC-983E-85F74BEF83BF Q37196037-D60BCE65-0F1E-4F4E-AB06-C5941FB70B29 Q37277510-80FED296-0BFC-447A-B8BA-835C334DCAE2 Q37299197-698CC4E4-2E56-4D21-A3C2-3AC965155C97 Q37700004-5C0633E3-0D84-4B4C-927A-73806EFAE0AE Q39739692-03C06B6B-2F58-4070-BF11-C141C17EB502 Q39757200-48C8CBA2-D39F-40A3-81BF-1ED1EDBBCCCD Q39855602-427D8826-9BAE-4DE0-97E3-CE5515254EA8 Q40188934-A2DD51A5-6AF5-4AFA-B10A-31B39DED38EF Q41045924-F14A365A-BA89-4244-8622-8C7F9A7AAAD4 Q41613066-44E60DAF-40CA-4614-BE2A-7201D6C0E2AE Q46839310-4B461CA2-E6D4-4523-8E28-3939AF4DF291 Q48400772-311B407E-26E0-44FD-A77B-2926DE32B242 Q48915551-6A2001C0-3243-415F-B493-7B8E257CE87A Q49544561-0933AF2A-442A-4C28-965E-521B5DE4119E Q50130779-94B91389-ECFC-4B1B-A36E-289991FF8BA0 Q50626704-3D02FFE5-CDAA-4A5C-A49C-66650E7B0408 Q53723664-5040D193-7FA6-4616-BBDD-135E77C725BB

P2860

Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more.

http://www.wikidata.org/entity/Q33262818

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Epidemiological and clinical f ...... osed at the age of 50 or more.

@ast

Epidemiological and clinical f ...... osed at the age of 50 or more.

@en

Epidemiological and clinical f ...... osed at the age of 50 or more.

@nl

type

label

Epidemiological and clinical f ...... osed at the age of 50 or more.

@ast

Epidemiological and clinical f ...... osed at the age of 50 or more.

@en

Epidemiological and clinical f ...... osed at the age of 50 or more.

@nl

prefLabel

Epidemiological and clinical f ...... osed at the age of 50 or more.

@ast

Epidemiological and clinical f ...... osed at the age of 50 or more.

@en

Epidemiological and clinical f ...... osed at the age of 50 or more.

@nl

P1433

Q33262818-3F96842F-EB83-470E-9252-D03897E1379B

P1476

Q33262818-4C2053B9-05E0-4F3D-9AF9-607D042F0EF4

P2093

Q33262818-08387A4D-DAA9-42CF-9528-C3AAC227C308

Q33262818-39B1A456-9664-446B-A814-5C37AFA9419B

Q33262818-7B9877E7-4EC1-43F2-A447-89076DBB390C

Q33262818-9A990613-AE83-4CFC-954F-D7EA3A0DA783

Q33262818-CC125C4A-0B5C-4FEC-B5FE-6198DA6C15E3

Q33262818-CD9EF657-F5EF-4D4F-84D2-823B526FD12F

P2860

Q33262818-125EAB73-DFB4-46A6-84B0-3548D4A8CC63

Q33262818-12E9A38E-D64C-4F00-88CE-27AD0EB6FA3B

Q33262818-356B3614-1ED6-4F08-B068-B3E63AB39D56

Q33262818-4DF4D5B5-1C18-4FDB-B539-A92D468807FC

Q33262818-5E87FF82-AFB0-4BE1-B3CE-45FD7CB1BE21

Q33262818-75D99F51-FF06-4AE2-80DB-71B99A6AD2C2

Q33262818-7A16E9DA-1ABF-4637-86E8-EF64A28D88EB

Q33262818-7A5A0734-AB39-455E-BE87-0D1D3EC71DC5

Q33262818-7CC955DC-C36A-4763-B54B-1B04EF3B92AD

Q33262818-80D85AA5-50E6-4CC3-84F2-69D37274C470

P2888

Q33262818-3CD39316-AC33-43C8-914B-7F1922DAA0A0

P304

Q33262818-43143FD2-B61A-435D-B861-2E76E4C48AD3

P31

Q33262818-90A8B6C1-95D8-4472-A9DA-136463B183FE

P356

Q33262818-31D8F974-4C0B-434D-875B-6B39B589C438

P478

Q33262818-85340748-CEDC-4CBA-8C8F-209E5A23F91A

P50

Q33262818-C58EC42A-9E47-4F5B-8BE7-94BF010C7715

P577

Q33262818-318C4516-F92D-4C0E-9C2E-13129838BA38

P5875

Q33262818-B63DEF5F-822B-4B67-96AC-B75960B2027C

P6179

Q33262818-EDEE3CCC-46F1-4EAD-A51E-B9ED66234CF0

P698

Q33262818-063D1A5A-F732-4BC6-8CA2-671CD8019594

P921

Q33262818-12244B86-50FC-4252-93A0-C0A264040753

Q33262818-D5047551-7014-472A-B964-7641101C43D0

P932

Q33262818-A76BE12E-9D11-4637-B137-08D0F83F6813

P356

1471-2334-6-159

P1433

BMC Infectious Diseases

P1476

Epidemiological and clinical f ...... nosed at the age of 50 or more

@en

P2093

Esperança Antón

http://www.w3.org/2001/XMLSchema#string

Ferran Segura

http://www.w3.org/2001/XMLSchema#string

Gemma Navarro

http://www.w3.org/2001/XMLSchema#string

MaJosé Amengual

http://www.w3.org/2001/XMLSchema#string

Manel Cervantes

http://www.w3.org/2001/XMLSchema#string

Montserrat Sala

http://www.w3.org/2001/XMLSchema#string

P2860

Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy

Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse

HIV in the elderly.

HIV infection and advanced age emerging epidemiological, clinical, and management issues.

HIV and older adults: clinical outcomes in the era of HAART.

The changing epidemiology of human immunodeficiency virus infection in older persons.

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

Greater effect of highly active antiretroviral therapy on survival in people aged > or =50 years compared with younger people in an urban observational cohort.

Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation.

Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens.

P2888

1471-2334-6-159

P304

159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-6-159

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

María-Mercedes Nogueras

P577

2006-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6708952

http://www.w3.org/2001/XMLSchema#string

P6179

1050095587

http://www.w3.org/2001/XMLSchema#string

P698

17087819

http://www.w3.org/2001/XMLSchema#string

P921

P932

1654166

http://www.w3.org/2001/XMLSchema#string